Entry |
|
Name |
Acoramidis (USAN) |
Formula |
C15H17FN2O3
|
Exact mass |
292.1223
|
Mol weight |
292.30
|
Structure |

|
Class |
|
Remark |
Product (DG03143): | D11973<JP/US> |
|
Efficacy |
Amyloidogenesis suppressant |
Comment |
Treatment of patients with transthyretin amyloidosis
|
Target |
|
Pathway |
|
Metabolism |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01E OTHER CARDIAC PREPARATIONS
C01EB Other cardiac preparations
C01EB25 Acoramidis
D11972 Acoramidis (USAN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03143 Acoramidis
D11972 Acoramidis
DG03188 UGT1A9 substrate
DG03143 Acoramidis
D11972 Acoramidis
DG03190 UGT2B7 substrate
DG03143 Acoramidis
D11972 Acoramidis
Target-based classification of drugs [BR:br08310]
Transporters
Other transporters
Others
TTR
D11972 Acoramidis (USAN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D11972
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG02924 UGT substrate
DG03183 UGT1A1 substrate
DG03143 Acoramidis
DG03188 UGT1A9 substrate
DG03143 Acoramidis
DG03190 UGT2B7 substrate
DG03143 Acoramidis
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 21
1 C8y C 12.5300 -12.6700
2 C8y C 12.5300 -14.0700
3 C8x C 13.7424 -14.7700
4 C8x C 14.9549 -14.0700
5 C8y C 14.9549 -12.6700
6 C8x C 13.7424 -11.9700
7 C6a C 16.1860 -11.9590
8 O6a O 17.3912 -12.6547
9 O6a O 16.1857 -10.5701
10 X F 11.3176 -14.7700
11 O2a O 11.3176 -11.9700
12 C1b C 10.1221 -12.6604
13 C1b C 8.9347 -11.9749
14 C1b C 7.7435 -12.6629
15 C8y C 6.5540 -11.9762
16 C8y C 6.6671 -10.5727
17 N4x N 5.3721 -10.0323
18 N5x N 4.4580 -11.0969
19 C8y C 5.1880 -12.2953
20 C1a C 7.8511 -9.8507
21 C1a C 4.6365 -13.6102
BOND 22
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 7 9 2
10 2 10 1
11 1 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 1
19 18 19 2
20 15 19 1
21 16 20 1
22 19 21 1
|